The landscape of dementia diagnosis has evolved dramatically with the arrival of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-based assessments that can detect Alzheimer's pathology a long time in advance of indications arise. While these technological developments symbolize amazing development in being familiar with